0 items

in your cart
$0.00

  • Search for Medications
  • Viewcart | Checkout
  • Manage Account
  •  
  • Click-to-Call  

Prescription Drug Search

Product Request Form

Ofatumumab is currently not available.

Our suppliers are constantly updating their product inventory and availability status. If you would like us to notify you when Ofatumumab becomes available, please fill out the form below.

Name:
Email:

*We value your privacy! We will never give, lease, sell or otherwise disclose your personal information. Period!

Search for a drug:

 

Browse Alphabetically:

A · B · C · D · E · F · G · H · I · J · K · L · M · N
O · P · Q · R · S · T · U · V · W · X · Y · Z · #

Information about SaveRxCanada.to

SSL Secured Website Certified Global Pharmacy Network Hacker Proof: Safe Shopping Experience 5th Anniversary 2002-2007

List of countries where we can ship Ofatumumab:

  • Albania
  • Australia
  • Austria
  • Azerbaijan
  • Bahamas
  • Barbados
  • Belarus
  • Belize
  • Bolivia
  • Cayman Islands
  • Cyprus
  • Estonia
  • Fiji
  • Georgia
  • Gibraltar
  • Greece
  • Honduras
  • India
  • Italy
  • Korea, South
  • Latvia
  • Lebanon
  • Lithuania
  • Luxembourg
  • Moldova, Republic of
  • Morocco
  • Norway
  • Panama
  • Portugal
  • Qatar
  • Russian Federation
  • Slovakia
  • Spain
  • Sri Lanka
  • Sweden
  • Tonga
  • Tunisia
  • Turkey
  • United Kingdom, UK
  • United States, US
View All Countries

Latest news releases on Ofatumumab:

Ofatumumab - Genmab - Home

Ofatumumab is a human monoclonal antibody which targets an epitope in the CD20 molecule encompassing parts of the small and large extracellular loops.

A Phase 3 Study of Ibrutinib (PCI-32765) Versus Ofatumumab ...

The purpose of the study is to evaluate whether treatment with ibrutinib as a monotherapy results in a clinically significant improvement in progression free survival ...

Ibrutinib versus Ofatumumab in Previously Treated Chronic ...

Background In patients with chronic lymphoid leukemia (CLL) or small lymphocytic lymphoma (SLL), a short duration of response to therapy or adverse cytogenetic ...

Ofatumumab for TTP in a Patient with Anaphylaxis ...

Ofatumumab in Rituximab-Allergic TTP A patient with refractory thrombotic thrombocytopenic purpura had anaphylaxis associated with rituximab that was mediated by ...

FDA Drug Safety Communication: Boxed Warning and new ...

The U.S. Food and Drug Administration (FDA) has approved changes to the prescribing information of the immune-suppressing and anti-cancer drugs Arzerra (ofatumumab ...

Ofatumumab Added to Fludarabine-Cyclophosphamide vs ...

Ofatumumab Added to Fludarabine-Cyclophosphamide vs Fludarabine-Cyclophosphamide Combination in Relapsed Subjects With Chronic Lymphocytic Leukemia

Nutzenbewertungsverfahren zum Wirkstoff Idelalisib (neues ...

Nutzenbewertungsverfahren zum Wirkstoff Idelalisib (neues Anwendungsgebiet: chronische lymphatische Leukämie in Kombination mit Ofatumumab)

Novartis Global Pipeline | Novartis

Discover the Novartis pipeline of over 200 projects in clinical development, many for medicines that could advance treatment standards for patients.

Rituxan (rituximab) for RA, NHL, CLL, GPA and MPA

the most important information i should know about rituxan: infusion reactions, severe skin and mouth reactions, hepatitis b virus (hbv) reactivation and progressive ...

Genmab - Home

Genmab is an international biotechnology company specializing in the creation and development of differentiated antibody therapeutics for the treatment of cancer.

Customer Service
1-866-799-3435 | Contact Form
Copyright © 2018 SaveRxCanada.to All rights reserved. Disclaimer | Privacy Policy
Accepted Credit Cards and Payment: VISA, MASTERCARD and eCHECK